SOBRsafe Raises $3.1 Million Through Warrant Exercise Agreements

SOBRsafe Inc. (NASDAQ: SOBR), a provider of next-generation alcohol detection technology, has entered into definitive agreements for the immediate exercise of certain outstanding warrants at a reduced exercise price of $1.05 per share. The transaction is expected to generate gross proceeds of approximately $3.1 million before fees and expenses, according to a press release.

In connection with the warrant exercise, the company will issue new unregistered Series E and Series F warrants to purchase an aggregate of 4.7 million shares. The offering is expected to close on or about July 16, 2026. Net proceeds from the transaction are designated for working capital and general corporate purposes. H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering.

This capital infusion comes as SOBRsafe continues to advance its alcohol detection technology, which detects and reports the presence of alcohol in real-time through the skin without requiring breath, blood, or urine samples. The company’s solutions target behavioral health, family law, and consumer markets, as well as licensing and integration opportunities.

The full press release is available at https://nnw.fm/jzJjF.

For more information about SOBRsafe, visit www.sobrsafe.com. The latest news and updates are available in the company’s newsroom at https://nnw.fm/SOBR.